Search filters

List of works by William A Parker

A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control

scientific article published on 17 December 2021

Antithrombotic therapy for patients with chronic coronary syndromes

scientific article published on 30 October 2020

Aspirin after PCI: in the twilight of its years?

scientific article published on 15 July 2020

Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

scientific article published on 07 January 2020

Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study.

scientific article published on 6 April 2017

Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus.

scientific article

Choosing a perspective on mortality with DAPT.

scientific article published on 18 December 2015

Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study

scientific article published on 31 May 2018

International Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclature

scientific article

Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.

scientific article published on 8 February 2016

New Antithrombotic Drugs in Acute Coronary Syndrome

scientific article published on 30 June 2020

Novel approaches to P2Y12 inhibition and aspirin dosing

scientific article published on 19 January 2020

Offset of ticagrelor prior to coronary artery bypass graft surgery for acute coronary syndromes: effects on platelet function and cellular adenosine uptake

scientific article published on 02 January 2020

Pharmacology and potential role of selatogrel, a subcutaneous platelet P2Y12 receptor antagonist

scientific article published on 17 February 2020

Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention

scientific article published on 16 June 2020

Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary intervention: a GLOBAL LEADERS substudy

scientific article published on 26 December 2020

Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment

scientific article published on 19 October 2020

Ticagrelor: agonising over its mechanisms of action.

scientific article

Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome

scientific article published on 13 February 2019